Examining Employment Data Is Useful In Assessing Biomedical Ph.D. Training

Are we overproducing Ph.D.'s in biomedical sciences? If so, should we regulate future Ph.D. production? To address these questions, we need to examine the data. Biomedical Ph.D. production has increased dramatically. In 1995, United States institutions awarded 5,878 new Ph.D.'s in biomedical sciences, a 55 percent increase over the 3,791 degrees in 1985 (Washington, D.C., National Research Council, Survey of Earned Doctorates, unpublished survey). What forces drove this increase? The number

Written byHoward Garrison
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Biomedical Ph.D. production has increased dramatically. In 1995, United States institutions awarded 5,878 new Ph.D.'s in biomedical sciences, a 55 percent increase over the 3,791 degrees in 1985 (Washington, D.C., National Research Council, Survey of Earned Doctorates, unpublished survey). What forces drove this increase? The number of biology graduate students with research assistantships doubled from 1977 to 1985, while other forms of student aid remained level or declined. This suggests that the demand for research assistants was associated with increased production of new Ph.D.'s.

The growing demand for graduate students has been met by an increase in the number of non-U.S. citizens in U.S. graduate programs. Doctorates awarded to non-U.S. citizens rose from 587 in 1985 to 2,031 in 1995, while the number of Ph.D.'s earned by U.S. citizens grew from 3,050 in 1985 to 3,746 in 1995. (Citizenship status was not reported by 154 Ph.D.'s in 1985 and by ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies